Page 116 - 北京京煤集团总医院第十一届·2023学术年会论文集
P. 116

北京京煤集团总医院                                                          第十一届·2023 学术年会论文集

                   1189.
                   [7]  章韵,郑霞.  脓毒症患者肠道的病理生理学改变[J].  临床内科杂志,2021,38(9):584-587.

                   [8]  Huang M, Cai S, Su J. The Pathogenesis of Sepsis and Potential Therapeutic Targets[J]. Int J
                   Mol Sci. 2019, 20(21):5376.
                   [9]  杨铁柱,刘燕.  基于“脾主肌肉”理论探讨脓毒症高代谢的中医研究思路和治疗对策[J].

                   世界中西医结合杂志,2021,11:2147-2150.

                   [10] Barber  G,  Tanic  J,  Leligdowicz  A.  Circulating  protein  and  lipid  markers  of  early  sepsis
                   diagnosis and prognosis: a scoping review[J]. Curr Opin Lipidol. 2023, 34(2):70-81.
                   [11] 陈谦,蒋文强.脓毒症患者糖脂代谢紊乱与免疫功能和病情及预后的相关性分析[J].中国

                   医药,2023,18(01):71-76.
                   [12] Aleman  L,  Guerrero  J.  Hiperglicemia  por  sepsis:  del  mecanismo  a  la  clínica  [Sepsis
                   hyperglycemia in the ICU: from the mechanism to the clinic] [J]. Rev Med Chil. 2018 , 146(4): 502-

                   510.
                   [13] Singer P, Blaser AR, Berger MM, et al. ESPEN guideline on clinical nutrition in the intensive
                   care unit[J]. Clin Nutr, 2019, 38(1): 48-79.
                   [14] Puthucheary ZA, Rawal J, McPhail M, et al. Acute skeletal muscle wasting in critical illness[J].

                   JAMA, 2013, 310(15): 1591-1600.
                   [15] Martindale  R,  Patel  JJ,  Taylor  B,  et  al.  Nutrition  therapy  in  critically  ill  patients  with
                   coronavirus disease 2019[J]. JPEN J Parenter Enteral Nutr, 2020, 44(7): 1174-1184.

                   [16] 颜骏,蔡燕,张清艳,等.  脓毒症早期肠道菌群失调相关危险因素及其对预后的影响[J].  中
                   华危重症医学杂志(电子版),2020,05:328-333.

                   [17] 梁群,薛鸿征,冯文佳.  不同营养支持途径对脓毒症患者的影响综述[J].  解放军医学院学
                   报,2021,10:1110-1113.

                   [18] Kondrup J, Rasmussen HH, Hamberg O, et al. Nutritional risk screening (NRS 2002): a new
                   method based on an analysis of controlled clinical trials[J]. Clin Nutr. 2003, 22(3):321-336.
                   [19] Brascher JMM, Peres WAF, Padilha PC. Use of the modified "Nutrition Risk in the critically
                   ill" score and its association with the death of critically ill patients. Clin Nutr ESPEN[J]. 2020,

                   35:162-166.
                   [20] 乔永涛,刘惠双,刘杰,等.NRS2002 量表对危重症患者的应用价值[J].中国卫生工程

                   学,2021,20(02):287-289.
                   [21] 李云婷,李芬,邢柏.机械通气老年脓毒症患者并发重症监护病房获得性衰弱的风险因素

                   分析及 mNUTRIC 评分的早期预测价值[J].实用医学杂志,2022,38(20):2568-2573.
                   [22] McClave SA, Taylor BE, Martindale RG, et al. Guidelines for the provision and assessment of

                   nutrition support therapy in the adult critically ill patient: Society of Critical Care Medicine (SCCM)
                   and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.) [J]. JPEN J Parenter Enteral
                   Nutr, 2016, 40 (2): 159-211.
                   [23] American  Society  for  Parenteral  and  Enteral  Nutrition.  Guidelines  for  the  Provision  and


                                                          - 112 -
   111   112   113   114   115   116   117   118   119   120   121